On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...